Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Dosage Forms > Final 4 > Flashcards

Final 4 Flashcards

1
Q

What is the current estimate of the cost to bring a new drug to market?

A

$2.5 billion, more than doubled in the past 10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What types of drug products must meet USP standards?

a. Prescription drugs
b. OTC Drugs
c. Generic Drugs
d. All of the above

A

d. All of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What else should we mention regarding an ideal aerosol?

a. It is safe
b. Product should be inexpensive for the customer
c. Device is portable
d. Formulation is stable at ambient conditions

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The scale is in _____

A

micrograms, grams, nanogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The main reason the solution cools in a jet nebulizer is because of _____

A

Evaporation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In this specific example, what sentence describes the dry powder inhaler that is least efficient?

A

DiscHaler (lower FPF means higher loss) AND DiscHaler (Lower FPF means lower number of small particles)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

True/False: Suppositories are the only dosage form available for rectal and vaginal delivery

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

If you have a lipophilic drug, and would like to design a suppository with a slow release rate, the base you should choose is _____

A

A hydrogenated vegetable oil base

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which of the following is possible using nasal delivery?

a. Local delivery
b. Systemic delivery
c. Delivery to the CNS
d. All of the Above

A

d. All of the Above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

By conjugating PEG to a protein, ______

a. The bigger size increases half-life
b. PEG may reduce immunogenicity of the protein
c. PEG may interfere with target binding
d. All of the above

A

d. All of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The largest number of topical products are formulated as _____

A

Creams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The most common method of enhancing penetration of an active molecule through skin is _____

A

Sorption promoting solvents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does ICH stand for?

A

International Conference on Harmonization (of Technical Requirements for Registration of Pharmaceuticals for Human Use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the product’s intended use containing the following excipients: croscarmellose sodium, hypromellose 2910, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, povidone, sodium lauryl sulfate, titanium dioxide and triacetin?

A

Immediate release tablet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the purpose of the croscarmellose sodium in the formulation?

A

Disintegrant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Is the extended release tablet film coated?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the intended use for: ascrobic acid, flavor, carboxymethylcellulose sodium, anhydrous citric acid, glycerin, magnerisum aluminum silicate, orane oil, concentrate, polysorbate 40, purified water, no benzoate, sucrose, vanillin, FD&C yellow No.6?

A

Oral suspension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which of the following is the US adopted name in lipitor (atorvastation calcium) tablets for oral administration?

A

Atorvastatin calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

“Ostwald’s rule” is that the least stable crystal polymorph?

A

Tend to crystalize first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Which of the following are not considered part of pharmaceutical product SISPQ?

A

Preparation

SISPQ = Safety-Integrity-Strength-Purity-Quality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Roughly how many routes of administration are described by the FDA?

A

120

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which of the following routes of administration can be used for systemic drug delivery?

a. IV
b. Rectal
c. Nasal
d. Pulmonary
e. All of the above

A

e. All of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which of the following is an invasive route of administration?

A

IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Which of the following would NOT be considered an invasive type of delivery?

A

Rectal suppository

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Noninvasive routes of administration ALWAYS _____

A

Require the drug to pass across a mucosal or cellular barrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the most important stability category and determines the expiration period?

A

Each is equally important and contributes to determining product shelf-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

True/False: Color changes can indicate chemical instability

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

True/False: Two agencies that regulate are the FDA and USP

A

False

29
Q

True/False: Product shelf-life stability is determined by accelerated stability testing

A

False

30
Q

Which of the following statements are true about lyophilization?

a. Properly executed lyophilization cycles result in minimal product reconstitution times
b. injectable products and fast dissolving oral tablets are available as freeze dried products
c. The pharmacist must properly store, reconstitute and label lyophilized injectable products
d. All of the above

A

d. All of the above

31
Q

Which of the following is a surfactant?

A

Sodium lauryl sulfate

32
Q

. The higher number capsule sizes (I.e. 0 -> 1 -> 2…) are desired because:

a. “they get larger and therefore easier to pick up”
b. “better for lower density, higher volume powders”
c. “harder to swallow”
d. None of the above

A

d. None of the above

33
Q

A size 1 capsule (0.5 cc volume) can hold what amount of powder having a tamped powder density of 0.5 g/cc?

A

250 mg

34
Q

Capsules are banded because _____

A

Prevents tampering/adulteration

35
Q

True/False: Impurities are likely a critical attribute for release testing of a new batch of capsules

A

True

Critical attribute for release testing = AAIDI
Assay, Appearance, Identity, Dissolution, Impurities

36
Q

True/False: Sterility is a likely critical attribute for release testing of a new batch of capsules

A

False

Critical attribute for release testing = AAIDI
Assay, Appearance, Identity, Dissolution, Impurities

37
Q

Dissolution is a likely critical attribute for release testing of a new batch of capsules

A

True

Critical attribute for release testing = AAIDI
Assay, Appearance, Identity, Dissolution, Impurities

38
Q

Taste is a likely critical attribute for release testing of a new batch of capsules

A

False

Critical attribute for release testing = AAIDI
Assay, Appearance, Identity, Dissolution, Impurities

39
Q

True/False: Identity is a likely critical attribute for release testing of a new batch of capsules

A

True

Critical attribute for release testing = AAIDI
Assay, Appearance, Identity, Dissolution, Impurities

40
Q

True/False: Powder particle size and flow are likely critical attribute for release testing of a new batch of capsules

A

False

Critical attribute for release testing = AAIDI
Assay, Appearance, Identity, Dissolution, Impurities

41
Q

True/False: Appearance is a likely critical attribute for release testing of a new batch of capsules

A

True

Critical attribute for release testing = AAIDI
Assay, Appearance, Identity, Dissolution, Impurities

42
Q

True/False: Tamper resistance is a likely critical attribute for release testing of a new batch of capsules

A

False

Critical attribute for release testing = AAIDI
Assay, Appearance, Identity, Dissolution, Impurities

43
Q

True/False: Assay is a likely critical attribute for release testing of a new batch of capsules

A

True

Critical attribute for release testing = AAIDI
Assay, Appearance, Identity, Dissolution, Impurities

44
Q

True/False: One year stability results are a likely critical attribute for release testing of a new batch of capsules

A

False

Critical attribute for release testing = AAIDI
Assay, Appearance, Identity, Dissolution, Impurities

45
Q

Functional tablet coatings are not to be split because _____

A

The function of the coating is lost

46
Q

In general, the main purpose of tablet formulations is to:

a. Make the material more compressible
b. Assure weight uniformity across tablets
c. Assure active drug uniformity across tablets
d. Assurance that tablets readily disintegrate and dissolve as intended
e. All of the above

A

e. All of the above

47
Q

The purpose of a tablet lubricant is to ______

A

Minimize friction during tablet ejection from the die hole

48
Q

If a tablet is too soft, then to make harder tablets _______

A

a. Increase the compression force
b. Engage pre-compression roller to double up on compressions per unit
c. Increase compression dwell time by slowing down the process
d. Alter formulation to be more compressible
e. All of the above

49
Q

Which of the following critical quality attributes should be included in stability testing to assure no change during the shelf life of the tablet?

A

Weight variation and/or content uniformity

50
Q

What is the primary source of contamination during compounding?

A

Personnel

51
Q

CQAs help ensure:

a. Patient safety
b. Efficacy of the drug product
c. Quality of the drug product
d. All of the above

A

d. All of the above

CQA = Critical Quality Attribute

52
Q

Controlling CQA for a drug product is ____

A

a. A FDA requirement
b. An EMA (European Medicines Agency) requirement
c. A health Canada requirement
d. A PMDA L(Japan’s pharmaceuticals and Medical Devices Agency) requirement

53
Q

During aseptic preparation of sterile dosage forms it is OK to:

a. pick up items off the floor during compounding
b. handle products with torn gloves/gown
c. leave room and return to compounding without changing gloves or gowning
d. ignore good aseptic technique
e. none of the above

A

e. none of the above

54
Q

For drug products confirmed to not have passed sterility testing you should _____

A

a. Perform an investigation to determine the root cause

b. Recall the lot of drug product that failed sterility testing

55
Q

When you receive a warning Letter from the FDA:

a. Ignore it
b. Provide a formal written response back to the FDA within a specific time frame
c. You can be personally found guilty of criminal charges
d. Risk having the facility shut down
e. B, C, and D

A
56
Q

How does bioavailability affect dosage form and concentration?

A

Most topical eye drops are lost to tears making the absorbed component quite small

57
Q

Ocular drugs can be administered systemically. What is the bioavailability in the eye for most drugs?

A

1%

58
Q

Which is currently a common ocular delivery system, which is the basis for the largest selling ocular drugs for 2017? What is the indication?

A

Intravitreal injection for macular degeneration

59
Q

True/False: Suppositories are the only dosage form available for rectal and vaginal delivery

A

False

60
Q

True/False: From a clinical pharmacology perspective, pediatric patients can be thought of as “small adults”.

A

False

61
Q

Children are often unable to swallow pills or capsules until age:

A

6-7

62
Q

When a new pediatric formulation is developed for use in children, bioavailability studies should be conducted in pediatric patients

A

False

63
Q

True/False: When a new pediatric formulation is developed for use in children, bioavailability studies should be conducted in pediatric patients

A

False

64
Q

The largest number of topical products are formulated as _____

A

Creams

65
Q

The most common method of enhancing penetration of an active molecule through skin is _____

A

Sorption promoting solvents

66
Q

What biodegradable polymer have we discussed before?

A

PLGA

67
Q

True/False: PLGA is used frequently because it has ideal release characteristics

A

False

68
Q

By conjugating PEG to a protein _____

a. The bigger size increases half-life
b. PEG may reduce immunogenicity of the protein
c. PEG may interfere with target binding
d. All of the above

A

d. All of the above

Dosage Forms (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions